Dr Reddys Laboratories (RDY) Divestments (2012 - 2016)
Dr Reddys Laboratories (RDY) posted quarterly Divestments of $2.1 billion for Q4 2016, up 122.86% year-over-year from $924.8 million in Q1 2016, and up 107.92% quarter-over-quarter from -$26.0 billion in Q3 2016.
Dr Reddys Laboratories (RDY) Divestments (2012 - 2016) Analysis & Trends
Dr Reddys Laboratories' Divestments history runs 4 years deep, the most recent figure standing at $2.1 billion for Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 4.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 65.64 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.06 Bn |
| Sep 30, 2016 | -26.04 Bn |
| Dec 31, 2015 | -9.02 Bn |
| Sep 30, 2015 | -1.61 Bn |
| Jun 30, 2015 | -4.64 Bn |
| Dec 31, 2013 | 3.17 Bn |
| Sep 30, 2013 | 1.87 Bn |
| Jun 30, 2013 | -5.00 Bn |
| Dec 31, 2012 | -2.35 Bn |
| Sep 30, 2012 | -2.42 Bn |
| Jun 30, 2012 | -4.10 Bn |